- Home
- STTK vs UPLD Comparison
STTK vs UPLD Comparison
Compare STTK & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- UPLD
- Stock Information
- Founded
- STTK 2016
- UPLD 2010
- Country
- STTK United States
- UPLD United States
- Employees
- STTK N/A
- UPLD N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- UPLD Computer Software: Prepackaged Software
- Sector
- STTK Health Care
- UPLD Technology
- Exchange
- STTK Nasdaq
- UPLD Nasdaq
- Market Cap
- STTK 59.7M
- UPLD 67.6M
- IPO Year
- STTK 2020
- UPLD 2014
- Fundamental
- Price
- STTK $1.24
- UPLD $2.53
- Analyst Decision
- STTK Hold
- UPLD Hold
- Analyst Count
- STTK 3
- UPLD 3
- Target Price
- STTK $2.00
- UPLD $3.75
- AVG Volume (30 Days)
- STTK 357.1K
- UPLD 146.1K
- Earning Date
- STTK 11-14-2024
- UPLD 11-07-2024
- Dividend Yield
- STTK N/A
- UPLD N/A
- EPS Growth
- STTK N/A
- UPLD N/A
- EPS
- STTK N/A
- UPLD N/A
- Revenue
- STTK $6,435,000.00
- UPLD $278,945,000.00
- Revenue This Year
- STTK $115.09
- UPLD N/A
- Revenue Next Year
- STTK N/A
- UPLD N/A
- P/E Ratio
- STTK N/A
- UPLD N/A
- Revenue Growth
- STTK 382.75
- UPLD N/A
- 52 Week Low
- STTK $1.07
- UPLD $1.79
- 52 Week High
- STTK $11.76
- UPLD $5.28
- Technical
- Relative Strength Index (RSI)
- STTK 38.29
- UPLD 55.86
- Support Level
- STTK $1.14
- UPLD $2.46
- Resistance Level
- STTK $1.56
- UPLD $2.95
- Average True Range (ATR)
- STTK 0.12
- UPLD 0.16
- MACD
- STTK 0.07
- UPLD 0.04
- Stochastic Oscillator
- STTK 24.42
- UPLD 49.40
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About UPLD Upland Software Inc.
Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.